Incidence and relationship of obesity with serum ferritin , lipid profile, uric acid and urea at Obesity Medical Center in Iraq

Emad Mahmoud Eltayef


Obesity is an excessive accumulation of energy in the form of body fat which impairs health. The main cause of obesity epidemic is clear: overeating, especially that of foods, which are rich in fats, extracted sugars or refined starches. This combined with decline in physical activity results in an imbalance of intake and expenditure of calories, resulting in excess weight and eventually obesity. Co-morbidities commonly associated with obesity include diabetes, cardiovascular and respiratory disease, dyslipidemia, degenerative joint disease, stress incontinence and some form of tumors and other various diseases. In clinical practice, serum ferritin is used as a screening tool to detect iron deficiency. However, its reliability in obesity has been questioned.
The objective of this study was to assess and compare the incidence of obesity , hyperferritinemia , hyperlipidemia and hypouricemia among middle aged hypertensive patients in the local setting as well as, to shed light on this issue, we have compared serum ferritin levels and other classical indices between obese males and females, finally to evaluate the main factors accounting for ferritin levels .This cross-sectional study was conducted at Obesity Medical Center at Al-Kindy Teaching Hospital, Baghdad, from January to march 2016. One hindered and nine patients seen in the medical outpatient center were enrolled in the study plus to participate of 61 subjects as control. On the basis of body mass index (BMI), 169 participants were divided into two groups: BMI 18.5–25 kg/m2 non obese (control), BMI ≥ 30 kg/m2 obese subjects.
The main demographic features data of the study population appeared that , SP and DP were significantly higher in obese patients (P<0.05) compared with control. Serum Hb was significantly lower in obese male when compared with the non-obese group and no difference in female group was observed. In addition, the levels of serum lipid profile and other studied parameters according to gender showed the following results: The mean levels of cholesterol, Tg, LDL, VLDL, glucose, ferritin had significantly higher in obese (for both genders) when compared with the non-obese group.

Dissimilarly, the mean concentration of HDL, uric acid, urea in obese groups had significantly lower when compared with the control in both genders.
The comparison results between obese males and females concluded that female subjects had significantly higher BMI, and lower in VLDL and ferritin levels compared to male subjects. Present study includes all types of correlation between parameters and appeared the following results:
It was observed a significant correlation between serum cholesterol levels and BMI (-0.637 ,p=0.048 ) , VLDL and age ( 0.876 ,p=0.001 ) ,uric acid and glucose (-0.686 ,p=0.028) ,urea and SP (0.778 ,P=0.008 ) ferritin and SP (0.709 ,P=0.022 ) in males group. As well as, a significant correlation in females group was found between cholesterol and HDL (-0.0665,P=0.036) ,cholesterol and BMI (0.724 ,P=0.018 ) ,urea and BMI (-0.633 , p=0.050 ) .In obese patients (n=109), stepwise linear regression analysis showed that, serum ferritin levels were independently correlated with LDL ,VLDL levels and age, (P< 0.001).


Obesity, ferritin , lipid profile , Body Mass index , Obesity complications.

Full Text:



- WHO, Obesity and Overweight Fact Sheet N°311, WHO, Geneva, Switzerland, 2015 .

- J. K. Dibaise and A. E. Foxx-Orenstein, “Role of the gastroenterologist in managing obesity,” Expert Review of Gastroenterology and Hepatology, vol. 7, no. 5, pp. 439–451, 2013.


- D. W. Haslam and W. P. James, “Obesity,” The Lancet, vol. 366, no. 9492, pp. 1197–1209, 2005.

- C. Hutchinson, “A review of iron studies in overweight and obese children and adolescents: a double burden in the young?” European Journal of Nutrition, vol. 55, no. 7, pp. 2179–2197, 2016.

- A. C. Cepeda-Lopez, A. Melse-Boonstra, M. B. Zimmermann, and I. Herter-Aeberli, “In overweight and obese women, dietary iron absorption is reduced and the enhancement of iron absorption by ascorbic acid is one-half that in normal-weight women,” The American Journal of Clinical Nutrition, vol. 102, no. 6, pp. 1389–1397, 2015.

- J. Baumgartner, C. M. Smuts, I. Aeberli, L. Malan, H. Tjalsma, and M. B. Zimmermann, “Overweight impairs efficacy of iron supplementation in iron-deficient South African children: a randomized controlled intervention,” International Journal of Obesity, vol. 37, no. 1, pp. 24–30, 2013.

- L. Zhao, X. Zhang, Y. Shen, X. Fang, Y. Wang, and F. Wang, “Obesity and iron deficiency: a quantitative meta-analysis,” Obesity Reviews, vol. 16, no. 12, pp. 1081–1093, 2015.

- H. L. Cheng, C. Bryant, R. Cook, H. O'Connor, K. Rooney, and K. Steinbeck, “The relationship between obesity and hypoferraemia in adults: a systematic review,” Obesity Reviews, vol. 13, no. 2, pp. 150–161, 2012.

-Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384:766–781 .

- Gartner A, Berger J, Bour A, E Ati J, Traissac P, Landais E, et al. Assessment of iron deficiency in the context of the obesity epidemic: importance of correcting serum ferritin concentrations for inflammation. Am. J .Clin. Nutr. 2013; 98(3):821–826.

- Menzie CM, Yanoff LB, Denkinger BI, McHugh T, Sebring NG, Calis KA, et al. Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc. 2008; 108(1):145–18.

- A. Vehapoglu, S. Turkmen, N. Goknar, and Ö. F. Özer, “Reduced antioxidant capacity and increased subclinical inflammation markers in prepubescent obese children and their relationship with nutritional markers and metabolic parameters,” Redox Report, vol. 21, no. 6, pp. 271–280, 2016.

- .P. Gupta Bansal, G. Singh Toteja, N. Bhatia et al., “Deficiencies of serum ferritin and vitamin B12, but not folate, are common in adolescent girls residing in a slum in Delhi,” International Journal for Vitamin and Nutrition Research, vol. 85, no. 1-2, pp. 14–22, 2015.

- .H. T. O'Brien, R. Blanchet, D. Gagné, J. Lauzière, and C. Vézina, “Using soluble transferrin receptor and taking inflammation into account when defining serum ferritin cutoffs improved the diagnosis of iron deficiency in a group of Canadian preschool Inuit children from Nunavik,” Anemia, vol. 2016, Article ID 6430214, 10 pages, 2016.

- J.-W. Kim, D. H. Kim, Y. K. Roh et al., “Serum ferritin levels are positively associated with metabolically obese normal weight: a nationwide population-based study,” Medicine, vol. 94, no. 52, Article ID e2335, 2015.

-Y.-F. Huang, T.-S. Tok, C.-L. Lu, H.-C. Ko, M.-Y. Chen, and S. C. Chen, “Relationship between being overweight and iron deficiency in adolescents,” Pediatrics & Neonatology, vol. 56, no. 6, pp. 386–392, 2015.

- Oshang A, Bugge KH, Bjones CH, Borch-Iohnsen B, Neslein IL. Associations between serum ferritin and cardiovascular risk factors in healthy young men. A cross sectional study. Eur J Clin Nutr 1995; 49: 430–438. | PubMed |

- Jehn M, Clark JM, Guallar E. Serum ferritin and risk of the metabolic syndrome in US adults. Diabetes Care 2004; 27: 2422–2428. |

- Guillum RF. Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men: the Third National Health and Nutrition Examination Survey. Int J Obes Relat Metab Disord 2001; 25: 639–645. |

- Illouz F, Roulier V, Rod A, Gallois Y, Pellé CP, Aubé C et al. Distribution of adipose tissue: quantification and relationship with hepatic steatosis and vascular profiles of type 2 diabetic patients with metabolic syndrome. Diabetes Metab 2008; 34: 68–74. | |*

- Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448–454.|

- Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated c-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131–2135. | |

- Fernández-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003; 24: 278–301. | |

- Hernández C, Lecube A, Carrera A, Simó R. Soluble transferrin receptors and ferritin in Type 2 diabetic patients. Diabet Med 2005; 22: 97–101. | |

- WHO, Obesity and Overweight Fact Sheet N°311, WHO, Geneva, Switzerland, 2015.

- D. Herrera-Covarrubias, G. A. Coria-Avila, C. Fernández-Pomares, G. E. Aranda-Abreu, J. Manzo Denes, and M. E. Hernández, “Obesity as a risk factor in the development of cancer,” Revista Peruana de Medicina Experimental y Salud Pública, vol. 32, no. 4, pp. 766–776, 2015.

- A. Kohlgruber and L. Lynch, “Adipose tissue inflammation in the pathogenesis of type 2 diabetes,” Current Diabetes Reports, vol. 15, no. 11, article 92, 2015.

- J.-P. Bastard, M. Maachi, C. Lagathu et al., “Recent advances in the relationship between obesity, inflammation, and insulin resistance,” European Cytokine Network, vol. 17, no. 1, pp. 4–12, 2006.

- Richard H. , Denise F ,Lippincotts illustrated reviews . Biochemistry. 5 th ed .Williams and Wilkins / Philadelphia, 2011, p,40 .

- Tamai H, Ohsako N, Takeno K, Fukino O, Takahashi H, Kuma K, et al. Changes in thyroid function in euthyroid subjects with a family history of Graves' disease: a follow-up study of 69 patients. J Clin Endocrinol Metab 1980; 51(5):1123-1127.

- Eftekhari MH, Eshraghian MR, Mozaffari-Khosravi H, Saadat N, Shidfar F. Effect of iron repletion and correction of iron deficiency on thyroid function in iron-deficient Iranian adolescent girls. Pak J Biol Sci 2007;10: 255-60.

- Dillman E, Johnson DG, Martin J, Mackler B, Finch CA. Catecholamine elevation in iron deficiency. Am. J. Physiol. 1979; 237: 927-930.

- Pinhas-Hamiel O, Newfield RS, Koren I, Agmon A, Lilos P, Phillip M. Greater prevalence of iron deficiency in overweight and obese children and adolescents. Int. J. Obes. Relat. Metab. Disord. 2003; 27:416–418.

- Moayeri H, Bidad K, Zadhoush S, Gholami N, Anari S. Increasing prevalence of iron deficiency in overweight and obese children and adolescents (tehran adolescent obesity study) Eur. J. Pediatr. 2006; 165:813–814.

- Shi Z, Lien N, Kumar BN, Dalen I, Holmboe-Ottesen G. The sociodemographic correlates of nutritional status of school adolescents in jiangsu province, china. J. Adolesc. Health. 2005; 37:313–322.

- Tussing-Humphreys LM, Liang H, Nemeth E, Freels S, Braunschweig CA. Excess adiposity, inflammation, and iron-deficiency in female adolescents. J. Am. Diet. Assoc. 2009; 109:297–302.

- Sanad M, Osman M, Gharib A. Obesity modulate serum hepcidin and treatment outcome of iron deficiency anemia in children: a case control study. Ital J Pediatr. 2011;37 :34.

- Aigner E, Hinz C, Steiner K, Rossmann B, Pfleger J, Hohla F, et al. Iron stores, liver transaminase levels and metabolic risk in healthy teenagers. Eur. J. Clin. Investig. 2010; 40:155–163.

- Ackerman, Z.; Oron-Herman, M.; Grozovski, M.; Rosenthal, T.; Pappo, O.; Link, G.; Sela, B.A. Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction.

Hypertension 2005, 45, 1012–1018.

- Lanaspa, M.A.; Sanchez-Lozada, L.G.; Cicerchi, C.; Li, N.; Roncal-Jimenez, C.A.; Ishimoto, T.; Le, M.;Garcia, G.E.; Thomas, J.B.; Rivard, C.J.; et al. Uric acid stimulates fructokinase and accelerates fructose

metabolism in the development of fatty liver. PLoS ONE 2012, 7, e47948.

- Pagliassotti, M.J. Endoplasmic reticulum stress in nonalcoholic fatty liver disease. Annu. Rev. Nutr. 2012, 32,17–33.

- Zhang, C.; Chen, X.; Zhu, R.M.; Zhang, Y.; Yu, T.; Wang, H.; Zhao, H.; Zhao, M.; Ji, Y.L.; Chen, Y.H.; et al.Endoplasmic reticulum stress is involved in hepatic SREBP-1c activation and lipid accumulation in

fructose-fed mice. Toxicol. Lett. 2012, 212, 229–240.

- .De Oliveira, E.P.; Burini, R.C. High plasma uric acid concentration: causes and consequences.Diabetol. Metab. Syndr. 2012, 4, 12.

- Martinon, F.; Petrilli, V.; Mayor, A.; Tardivel, A.; Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440, 237–241.

- Bugianesi, E.; Manzini, P.; D’Antico, S.; Vanni, E.; Longo, F.; Leone, N.; Massarenti, P.; Piga, A.; Marchesini, G.;Rizzetto, M. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis innonalcoholic fatty liver. Hepatology 2004, 39, 179–187.

- Ford, E.S.; Cogswell, M.E. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care 1999,22, 1978–1983.

- Salonen, J.T.; Tuomainen, T.P.; Nyyssonen, K.; Lakka, H.M.; Punnonen, K. Relation between iron stores and non-insulin dependent diabetes in men: Case-control study. BMJ 1998, 317, 727.

- Kim, C.W.; Chang, Y.; Sung, E.; Shin, H.; Ryu, S. Serum ferritin levels predict incident non-alcoholic fatty liver disease in healthy Korean men. Metabolism 2012, 61, 1182–1188.

- Gillum, R.F. Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men—The third national health and nutrition examination survey. Int. J. Obes. Relat. Metab. Disord.2001, 25, 639–645.

- Piperno, A.; Trombini, P.; Gelosa, M.; Mauri, V.; Pecci, V.; Vergani, A.; Salvioni, A.; Mariani, R.; Mancia, G.Increased serum ferritin is common in men with essential hypertension. J. Hypertens. 2002, 20, 1513–1518.

- Williams, M.J.; Poulton, R.; Williams, S. Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women. Atherosclerosis 2002, 165, 179–184.

- Iwasaki, T.; Nakajima, A.; Yoneda, M.; Yamada, Y.; Mukasa, K.; Fujita, K.; Fujisawa, N.; Wada, K.; Terauchi, Y.Serum ferritin is associated with visceral fat area and subcutaneous fat area. Diabetes Care 2005, 28, 2486–2491

- Alam, F.; Memon, A.S.; Fatima, S.S. Increased Body Mass Index may lead to Hyperferritinemia Irrespective of Body Iron Stores. Pak. J. Med. Sci. 2015, 31, 1521–1526.

- Ellervik, C.; Marott, J.L.; Tybjaerg-Hansen, A.; Schnohr, P.; Nordestgaard, B.G. Total and cause-specific mortality by moderately and markedly increased ferritin concentrations: General population study and metaanalysis. Clin. Chem. 2014, 60, 1419–1428.

- Jian J, Pelle E, Huang X. Iron and menopause: does increased iron affect the health of postmenopausal women? Antioxid Redox Signal. 2009; 11: 2939–2943.

- Sullivan JL. Is stored iron safe? J Lab Clin Med. 2004:144:280-284. PMID: 15614249.

- A. Lecube, C. Hernández, D. Pelegrí, and R. Simó, “Factors accounting for high ferritin levels in obesity,” International Journal of Obesity, vol. 32, no. 11, pp. 1665–1669, 2008.

- S.-B. Chen, Y.-C. Lee, K.-H. Ser et al., “Serum C-reactive protein and white blood cell count in morbidly obese surgical patients,” Obesity Surgery, vol. 19, no. 4, pp. 461–466, 2009.



  • There are currently no refbacks.

Copyright (c) 2018 Al-Mustansiriyah Journal of Science

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2018 by Al-Mustansiriyah Journal of Science
ISSN: 1814-635X (Print), ISSN: 2521-3520 (online)